Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biopharmaceutical company with marketed products and a ...

The semi-invasive system developed by CIBR and its affiliated start-up NeuCyber NeuroTech have completed their first three ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products ...

aStroke Therapy Evaluation Programme, Academic Section of Geriatric Medicine, Cardiovascular and Medical Sciences Division, Royal Infirmary, Glasgow, UK Loss of functional movement is a common ...

It was with these considerations in mind that we undertook to examine our own experience with arterial emboli to determine what place, if any, the operation of embolectomy should play in the ...

Tingling in the head and face can have a number of possible causes, including upper respiratory and sinus infections, headache disorders, head injuries, and diabetes, among others. Clinically referred ...

Objective: The aim of this study was to investigate the characteristics of brain activity changes in patients with post-stroke balance dysfunction and their relationship with clinical assessment, and ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Several artificial intelligence (AI) companies are offering ways to automate time-consuming tasks usually performed by nurses and medical assistants. Hospitals say AI is helping their nurses work ...

The United States healthcare system is failing. We rank last among developed countries in healthcare performance, and Americans face lower life expectancy and growing chronic disease rates despite ...